Institution
World Heart Federation
Nonprofit•Geneva, Switzerland•
About: World Heart Federation is a nonprofit organization based out in Geneva, Switzerland. It is known for research contribution in the topics: Medicine & Global health. The organization has 72 authors who have published 131 publications receiving 8538 citations. The organization is also known as: The World Heart Federation & WHF.
Topics: Medicine, Global health, Population, Disease, Heart disease
Papers published on a yearly basis
Papers
American Heart Association1, Centers for Disease Control and Prevention2, American Academy of Family Physicians3, American Congress of Obstetricians and Gynecologists4, Society of Thoracic Surgeons5, American College of Cardiology6, National Institutes of Health7, American College of Physicians8, World Heart Federation9
TL;DR: Major randomized controlled clinical trials such as the Women’s Health Initiative have changed the practice of CVD prevention in women over the past decade and the investment in combating this major public health issue for women has been significant.
Abstract: Substantial progress has been made in the awareness, treatment, and prevention of cardiovascular disease (CVD) in women since the first women-specific clinical recommendations for the prevention of CVD were published by the American Heart Association (AHA) in 1999.1 The myth that heart disease is a “man’s disease” has been debunked; the rate of public awareness of CVD as the leading cause of death among US women has increased from 30% in 1997 to 54% in 2009.2 The age-adjusted death rate resulting from coronary heart disease (CHD) in females, which accounts for about half of all CVD deaths in women, was 95.7 per 100 000 females in 2007, a third of what it was in 1980.3,4 Approximately 50% of this decline in CHD deaths has been attributed to reducing major risk factors and the other half to treatment of CHD including secondary preventive therapies.4 Major randomized controlled clinical trials such as the Women’s Health Initiative have changed the practice of CVD prevention in women over the past decade.5 The investment in combating this major public health issue for women has been significant, as have the scientific and medical achievements.
2,063 citations
University of Auckland1, Union for International Cancer Control2, Pan American Health Organization3, Imperial College London4, Commonwealth Secretariat5, International Union Against Tuberculosis and Lung Disease6, Massey University7, Organisation for Economic Co-operation and Development8, International Diabetes Federation9, World Bank10, Brigham and Women's Hospital11, University of Ottawa12, University of London13, University of Sydney14, National Heart Forum15, University of Melbourne16, World Heart Federation17, Public Health Foundation of India18, University of Southampton19, Harvard University20, Yonsei University21
TL;DR: The Lancet NCD Action Group and the NCD Alliance propose five overarching priority actions for the response to the crisis and the delivery of five priority interventions--tobacco control, salt reduction, improved diets and physical activity, reduction in hazardous alcohol intake, and essential drugs and technologies.
1,611 citations
Complutense University of Madrid1, Hospital Universitario de Canarias2, University of Bonn3, University of Santiago de Compostela4, University College London5, Paris Diderot University6, University of Birmingham7, University of Pisa8, University of Amsterdam9, National and Kapodistrian University of Athens10, French Institute of Health and Medical Research11, World Heart Federation12, University of London13, Charité14, Hebrew University of Jerusalem15, Sheba Medical Center16, University of Hong Kong17, University of Graz18
TL;DR: The present review reports the proceedings of the workshop jointly organised by the EFP and the World Heart Federation, which has updated the existing epidemiological evidence for significant associations between periodontitis and CVD, the mechanistic links and the impact of periodontal therapy on cardiovascular and surrogate outcomes.
Abstract: Background In Europe cardiovascular disease (CVD) is responsible for 3.9 million deaths (45% of deaths), being ischaemic heart disease, stroke, hypertension (leading to heart failure) the major cause of these CVD related deaths. Periodontitis is also a chronic non-communicable disease (NCD) with a high prevalence, being severe periodontitis, affecting 11.2% of the world's population, the sixth most common human disease. Material and methods There is now a significant body of evidence to support independent associations between severe periodontitis and several NCDs, in particular CVD. In 2012 a joint workshop was held between the European Federation of Periodontology (EFP) and the American Academy of Periodontology to review the literature relating periodontitis and systemic diseases, including CVD. In the last five years important new scientific information has emerged providing important emerging evidence to support these associations RESULTS AND CONCLUSIONS: The present review reports the proceedings of the workshop jointly organised by the EFP and the World Heart Federation (WHF), which has updated the existing epidemiological evidence for significant associations between periodontitis and CVD, the mechanistic links and the impact of periodontal therapy on cardiovascular and surrogate outcomes. This review has also focused on the potential risk and complications of periodontal therapy in patients on anti thrombotic therapy and has made recommendations for dentists, physicians and for patients visiting both the dental and medical practices.
1,028 citations
Nowell H. Phelps, Rosie K. Singleton, Bin Zhou, Rachel A. Heap +1749 more•Institutions (408)
TL;DR: A pooled analysis of 3663 population-representative studies reveals worldwide trends in underweight and obesity from 1990 to 2022, covering 222 million children, adolescents, and adults, with significant variations in prevalence across regions and age groups.
Abstract: Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 populationrepresentative studies with 222 million children, adolescents, and adults NCD Risk Factor Collaboration (NCD-RisC)
444 citations
TL;DR: The risk of being nonadherent (MAQ <20) was associated with younger age, depression, being on a complex medication regimen, poorer health insurance coverage, and a lower level of social support, with consistent findings across countries.
362 citations
Authors
Showing all 72 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Valentin Fuster | 179 | 1462 | 185164 |
| Sidney C. Smith | 169 | 467 | 267569 |
| Darien Wood | 160 | 2174 | 136596 |
| Karen Sliwa | 83 | 422 | 68902 |
| David R. Wood | 79 | 608 | 48430 |
| Bongani M. Mayosi | 78 | 403 | 68737 |
| Pekka Puska | 71 | 313 | 29164 |
| K. Srinath Reddy | 70 | 243 | 37154 |
| Samuel S. Gidding | 68 | 279 | 32888 |
| Pablo Perel | 57 | 199 | 14640 |
| Abhishek Sharma | 52 | 426 | 9715 |
| Fausto J. Pinto | 46 | 442 | 13308 |
| Sania Nishtar | 32 | 105 | 16505 |
| Fiona Wong | 27 | 44 | 1600 |
| Shiva Raj Mishra | 24 | 134 | 5583 |
Related Institutes (5)
Performance Metrics
| Year | Papers |
|---|---|
| 2024 | 9 |
| 2023 | 7 |
| 2021 | 23 |
| 2020 | 18 |
| 2019 | 10 |
| 2018 | 7 |